Anthony El-Khoueiry, MD
Enriched profileAssociate Professor of Clinical Medicine, Division of Medical Oncology; Associate Director for Clinical Research, USC Norris Comprehensive Cancer Center · USC Norris Comprehensive Cancer Center
Anthony El-Khoueiry is Associate Professor of Clinical Medicine, Division of Medical Oncology; Associate Director for Clinical Research, USC Norris Comprehensive Cancer Center at USC Norris Comprehensive Cancer Center. OpenAlex indexes 618 publications with 22,591 citations (h-index 60); ClinicalTrials.gov lists 4 registered studies with this person as an investigator.
Data verified 25 Aug 2026
Overview
Updated 27 Aug 2026
Anthony B. El-Khoueiry, MD, is Associate Professor of Clinical Medicine, Division of Medical Oncology at USC Norris Comprehensive Cancer Center / Keck School of Medicine of USC. The public record shows 618 publications with 22,591 citations (h-index 60), centered on Colorectal Cancer Treatments and Studies, Hepatocellular Carcinoma Treatment and Prognosis, Cancer Immunotherapy and Biomarkers. It also documents an investigator role on 4 registered clinical trials, industry payments reported by 22 companies, 5 NIH-funded awards (2009–2026).
- Most recent indexed publication: 2026 · Hepatology (Baltimore, Md.)
- Top research focus: Colorectal Cancer Treatments and Studies
- 4 registered trials on ClinicalTrials.gov
- Open Payments reporting from 22 companies
Generated from the cited public record · current as of 27 Aug 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 15 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 179.
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 27 Aug 2026
Listed as an investigator on 4 registered studies on ClinicalTrials.gov. The most recent:
- AU409 for the Treatment of Advanced Primary Liver Cancers or Solid Tumor With Liver Metastatic Disease
Sponsor: University of Southern California
- Guadecitabine and Durvalumab in Treating Patients With Advanced Liver, Pancreatic, Bile Duct, or Gallbladder Cancer
Sponsor: University of Southern California
- Recombinant EphB4-HSA Fusion Protein With Standard Chemotherapy Regimens in Treating Patients With Advanced or Metastatic Solid Tumors
Sponsor: University of Southern California
Industry payments
Updated 27 Aug 2026
22 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- Daiichi Sankyo Company LTDProgram year20254 payments
- AstraZeneca Pharmaceuticals LPProgram year20255 payments
- JAZZ PHARMACEUTICALS INC.Program year20251 payment
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Metabolism & gastrointestinal
100%Serotonin-3 Receptor Antagonist100%Ondansetron Hcl100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
Updated 27 Aug 2026
5 NIH research awards on record, funded 2009–2026 per NIH RePORTER. The latest:
- NCTN - Network Lead Academic Participating Site: USC
University of Southern California
FY2026$218,746UG1CA180830 - NCTN - Network Lead Academic Participating Site: USC
University of Southern California
FY2025$390,493UG1CA180830
Congress activity
Updated 27 Aug 2026
275 congress contributions (2004–2026) across AACR, ASCO, ASTRO, ESMO per OpenAlex. The most recent:
- Impact of claudin-1 (CLDN1) expression on molecular correlates and clinical outcomes in patients with advanced biliary tract cancers (BTCs).
ASCO Annual Meeting
ASCO2026Co-author
Published abstracts are attributed via the same ORCID-disambiguated authorship as publications, so each is DOI-verified. Podium roles (invited talks, session chairs) and oral/poster type are added as program data is confirmed.
Publications
Updated 27 Aug 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- A multicenter dose-defining/expansion phase 1b study of first-line regorafenib plus pembrolizumab in patients with advanced hepatocellular carcinoma.
Hepatology (Baltimore, Md.)
Clinical Trial2026 - Botensilimab (Fc-enhanced anti-cytotoxic lymphocyte-association protein-4 antibody) Plus Balstilimab (anti-PD-1 antibody) in Patients With Relapsed/Refractory Metastatic Sarcomas.
Journal of clinical oncology
Clinical Trial2025 - First-in-Human Phase I Study of a CD16A Bispecific Innate Cell Engager, AFM24, Targeting EGFR-Expressing Solid Tumors.
Clinical cancer research
Clinical Trial2025
Most-cited works
by citation count (OpenAlex)Network
Updated 27 Aug 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Online presence
Updated 27 Aug 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- LinkedIn
linkedin.com/in/anthony-el-khoueiry-72622961
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →linkedin.com ↗ - Other
uscnorriscancer.usc.edu/el-khoueiry
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →uscnorriscancer.usc.edu ↗ - Doximity
doximity.com/pub/anthony-el-khoueiry-md
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →doximity.com ↗
Mentions by others
where others cite or feature them- Other
onclive.com/authors/anthony-b-el-khoueiry-md
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →onclive.com ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 27 Aug 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →keckmedicine.org ↗
- Residency
Internal Medicine, USC
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →uscnorriscancer.usc.edu ↗ - Fellowship
Hematology and Oncology, USC
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →uscnorriscancer.usc.edu ↗ - Board Certified
Internal Medicine, American Board of Internal Medicine
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →keckmedicine.org ↗ - Board Certified
Medical Oncology, American Board of Internal Medicine
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →keckmedicine.org ↗
Editorial & leadership roles
journal and society appointments- Medical Director
Clinical Investigations Support Office, USC Norris
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →uscnorriscancer.usc.edu ↗ - Director
Phase I Program, USC Norris Comprehensive Cancer Center
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →uscnorriscancer.usc.edu ↗ - Member
National Cancer Institute Hepatobiliary Cancers Task Force
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →uscnorriscancer.usc.edu ↗
Awards & honors
honors on the public record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →uscnorriscancer.usc.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →uscnorriscancer.usc.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →uscnorriscancer.usc.edu ↗
Media & interviews
press, podcasts and appearances- Video/written interview series as recurring contributor
OncLive (e.g., "El-Khoueiry Elucidates Recent Updates in the Rapidly Evolving HCC Treatment Paradigm")
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →onclive.com ↗ - Interviewed by Neil Love
MD for "Hepatocellular Carcinoma Update – Conversations with Oncology Investigators" podcast/video series, Research To Practice
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →researchtopractice.com ↗ - Recurring author/contributor of clinical commentary
CancerNetwork
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →cancernetwork.com ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Heinz-Josef Lenz, MD
USC Norris Comprehensive Cancer Center
Adam Garsa, MD
USC Norris Comprehensive Cancer Center
Suisui Song
USC Norris Comprehensive Cancer Center